KWS SAAT SE & CO KGAA

Their core work

KWS is one of the world's five largest seed companies, headquartered in Einbeck, Germany, with over 160 years of plant breeding expertise spanning sugar beet, corn, cereals, and vegetables. In EU research projects, they contribute proprietary germplasm collections, industrial-scale phenotyping infrastructure, and direct access to commercial breeding pipelines — providing the critical link between academic plant science and market-ready crop varieties. Their H2020 participation focuses on photosynthesis improvement as a route to increasing yields and resource efficiency in European agriculture. As an industry partner embedded in research consortia, KWS provides the translational capacity that ensures laboratory findings can be validated in real breeding programs and delivered to farmers at scale.

What they specialise in

How they've shifted over time

Both H2020 projects were launched in the same year (2020), so the keyword split reflects two parallel research tracks rather than a genuine chronological progression. The first project (CAPITALISE) operates at the plant breeding and germplasm end — phenotyping, natural variation, translational science, and commercial impact assessment. The second (PhotoBoost) goes deeper into biochemical mechanisms — photorespiratory bypass, CO2 concentration, and carbon metabolism — applied to specific crop species including potato and rice. Taken together, they suggest KWS is simultaneously investing in breeding-level tools and in fundamental photosynthetic engineering, recognizing that commercially viable yield improvements will require progress on both fronts.

KWS is integrating photosynthesis engineering directly into its breeding pipelines, so future collaborations will need partners who can bridge fundamental plant biochemistry with agronomic performance validation at scale.

How they like to work

KWS participates exclusively as a consortium partner rather than a project coordinator — typical for large seed companies that contribute proprietary assets (germplasm, breeding pipelines) without taking on administrative project leadership. Their 27 unique partners across 11 countries from just two projects indicates involvement in large, multi-institutional RIA consortia that bring together plant scientists, biochemists, and agronomists from across Europe. This pattern signals that KWS functions as the "industry anchor" in these consortia, providing the commercial translation layer and access to real breeding materials that academic partners cannot supply.

KWS has engaged 27 unique partners across 11 countries through just two projects, reflecting involvement in large, multi-national RIA consortia rather than tight bilateral collaborations. Their network likely spans plant research institutes, universities, and agricultural industry actors across Western and Northern Europe.

What sets them apart

KWS brings something almost no academic institution can offer: a direct pipeline from research findings into commercial seed varieties that reach European farmers at scale. In photosynthesis research consortia — which typically struggle to demonstrate real-world agricultural impact — KWS provides the germplasm diversity, phenotyping infrastructure, and commercial breeding expertise needed to validate whether improvements actually work under field conditions. For any consortium addressing crop productivity, yield, or climate resilience, KWS represents the critical bridge between a successful EU project and a product that actually enters the market.

Highlights from their portfolio

• PhotoBoost
  Targets the fundamental biochemical bottlenecks of photosynthesis in C3 crops (potato, rice) by combining CO2 concentration mechanisms and photorespiratory bypass — among the most ambitious yield-improvement strategies currently pursued in plant science.
• CAPITALISE
  Aims to combine multiple photosynthesis improvement approaches for sustainability in European agriculture, with KWS contributing germplasm collections and translational expertise to anchor academic discoveries in commercial breeding reality.